Company / Operating Margin
Imunon, Inc. Operating Margin History
FY2015-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-4984.3%
FY2023
5-year range
-4984.3% / -3697.3%
FY2019-FY2023
Trend
-18.6%
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Margin has fluctuated over the past 7 years, ranging from -12329.2% in FY2015 to -3693.7% in FY2018.
Based on SEC 10-K filings.
-4984.3% in FY2023 with a 5-year CAGR of -1290.6%.
Declined from -3697.3% to -4984.3% over the past 2 years.
Operating Margin over time
Growth rates
- 3-Year Change
- -871.2pp
- 5-Year Change
- -1290.6pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2023, operating margin decreased 18.6% year-over-year.
- Peak operating margin was recorded in FY2018.
- Lowest operating margin in the period was in FY2015.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.82 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2023 | -4984.3% | -18.6% |
| FY2022 | -4201.4% | -13.6% |
| FY2021 | -3697.3% | +10.1% |
| FY2020 | -4113.1% | +2.4% |
| FY2019 | -4213.0% | -14.1% |
| FY2018 | -3693.7% | +70.0% |
| FY2015 | -12329.2% | - |
As of FY2023 · SEC 10-K · Updated Jun 24, 2026